Display options
Share it on

Open Med (Wars). 2017 May 02;12:115-124. doi: 10.1515/med-2017-0018. eCollection 2017.

Predictions and Outcomes of Atrial Fibrillation in the Patients with Acute Myocardial Infarction.

Open medicine (Warsaw, Poland)

Mihailo Vukmirović, Aneta Bošković, Irena Tomašević Vukmirović, Radoje Vujadinovic, Nikola Fatić, Zoran Bukumirić, Filip Vukmirović

Affiliations

  1. Department of Cardiology, Clinical Center of Montenegro, Montenegro, 20000 Podgorica.
  2. Department of Radiology, Clinical Center of Montenegro, Montenegro, 20000 Podgorica.
  3. Faculty of mechanical engineering, University of Montenegro, Montenegro, 20000 Podgorica.
  4. Department of Vascular Surgery, Clinical Centre of Montenegro, Ljubljanska 1, Montenegro, 20000 Podgorica.
  5. Institute of Medical Statistics and Informatics, Medical School, Belgrade, Serbia.
  6. Department of Pathology Clinical Centre of Montenegro, Montenegro, 20000 Podgorica.

PMID: 28730170 PMCID: PMC5444404 DOI: 10.1515/med-2017-0018

Abstract

The large epidemiological studies demonstrated that atrial fibrillation is correlated with high mortality and adverse events in patients with acute myocardial infarction. The aim of this study was to determinate predictors of atrial fibrillation develop during the hospital period in patients with acute myocardial infarction as well as short- and long-term mortality depending on the atrial fibrillation presentation. The 600 patients with an acute myocardial infarction were included in the study and follow-up 84 months. Atrial fibrillation develops during the hospital period was registered in 48 patients (8%). After adjustment by logistic regression model the strongest predictor of atrial fibrillation develop during the hospital period was older age, particularly more than 70 years (odds ratio 2.37, CI 1.23-4.58, p=0.010), followed by increased of Body Mass Index (odds ratio 1.17, CI 1.04-1.33, p=0.012), enlarged diameter of left atrium (LA) (odds ratio 1,18, CI 1,03-1,33, p=0,015) presentation of mitral regurgitation (odds ratio 3.56, CI 1.25-10.32, p=0.018) and B-type natriuretic peptide (odds ratio 2.12, CI 1.24-3.33, p=0.048).Patients with atrial fibrillation develop during the hospital period had a higher mortality during the hospital course (10.4% vs. 5.6%) p=0.179. as well as follow-up period of 84 months than patients without it (64.6% vs. 39.1%) p=0.569, than patients without it, but without statistically significance. Patients with AF develop during the hospital period had higher mortality during the hospital course as well as follow up period of 84 months than patients without it, but without statistically significance.

Keywords: Acute myocardial infarction; Atrial fibrillation; NSTEMI; STEMI

Conflict of interest statement

Conflict of interests: No authors report any conflict of interest.

References

  1. Pacing Clin Electrophysiol. 2008 Dec;31(12):1612-9 - PubMed
  2. J Obes. 2013;2013:729515 - PubMed
  3. Peptides. 2012 May;35(1):74-7 - PubMed
  4. Circ J. 2016 Jun 24;80(7):1615-23 - PubMed
  5. Arch Intern Med. 2006 Nov 27;166(21):2322-8 - PubMed
  6. Orv Hetil. 2016 Jan 31;157(5):191-3 - PubMed
  7. JAMA. 1991 Jul 10;266(2):231-6 - PubMed
  8. Arch Cardiovasc Dis. 2015 Nov;108(11):598-605 - PubMed
  9. J Am Coll Cardiol. 2007 Feb 6;49(5):565-71 - PubMed
  10. Cardiology. 1994;85(5):334-40 - PubMed
  11. Eur Heart J. 2009 May;30(9):1038-45 - PubMed
  12. Europace. 2018 Feb 1;20(2):263-270 - PubMed
  13. Am J Cardiol. 2016 Apr 15;117(8):1213-8 - PubMed
  14. Heart. 2005 Mar;91(3):369-70 - PubMed
  15. Circulation. 2004 Jul 27;110(4):364-7 - PubMed
  16. J Am Coll Cardiol. 2012 Aug 28;60(9):851-60 - PubMed
  17. Medicine (Baltimore). 2016 Nov;95(44):e5338 - PubMed
  18. Am Heart J. 1992 Aug;124(2):387-91 - PubMed
  19. BMC Cardiovasc Disord. 2017 Jan 4;17(1):2 - PubMed
  20. Circulation. 2004 Sep 21;110(12):1564-71 - PubMed
  21. Arch Intern Med. 2006 Nov 27;166(21):2362-8 - PubMed
  22. Am Heart J. 1990 May;119(5):996-1001 - PubMed
  23. Am J Cardiol. 2003 Nov 1;92(9):1031-6 - PubMed
  24. J Am Coll Cardiol. 2003 Apr 16;41(8):1264-72 - PubMed
  25. JAMA. 2004 Nov 24;292(20):2471-7 - PubMed
  26. Am J Cardiol. 2001 Jul 1;88(1):A7, 76-9 - PubMed
  27. Circulation. 2000 Mar 7;101(9):969-74 - PubMed
  28. Heart. 2010 May;96(9):683-8 - PubMed
  29. Eur Heart J. 1999 May;20(10):748-54 - PubMed
  30. Heart. 2001 Nov;86(5):527-32 - PubMed
  31. Heart. 2015 Jun;101(11):864-9 - PubMed
  32. Am J Cardiol. 1991 May 15;67(13):1135-6 - PubMed
  33. Acta Cardiol. 2001 Dec;56(6):375-80 - PubMed
  34. Can J Cardiol. 2015 Feb;31(2):203-10 - PubMed
  35. Heart. 2008 Jul;94(7):867-73 - PubMed
  36. J Am Coll Cardiol. 2010 May 25;55(21):2319-27 - PubMed
  37. Clin Cardiol. 1996 Mar;19(3):180-6 - PubMed
  38. Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):419-427 - PubMed
  39. Epidemiol Rev. 2007;29:98-114 - PubMed
  40. Rev Port Cardiol. 2015 Jun;34(6):403-10 - PubMed
  41. Circulation. 2003 Apr 15;107(14):1930-6 - PubMed
  42. Obesity (Silver Spring). 2014 Jun;22(6):1546-52 - PubMed
  43. J Am Coll Cardiol. 2004 Aug 4;44(3):564-8 - PubMed
  44. J Am Coll Cardiol. 1997 Aug;30(2):406-13 - PubMed
  45. Circulation. 2003 Jun 10;107(22):2786-92 - PubMed
  46. Am Heart J. 1998 Jan;135(1):21-8 - PubMed
  47. N Engl J Med. 2001 Oct 4;345(14):1014-21 - PubMed
  48. Am J Med. 2006 Feb;119(2):103-12 - PubMed
  49. Circ J. 2016 Jun 24;80(7):1534-6 - PubMed

Publication Types